Table 1 Baseline characteristics of the participants.
Variable | BSYJF (n = 70) | Placebo (n = 70) |
|---|---|---|
Demographics | ||
Mean age (SD), y | 63.91 (2.86) | 63.90 (2.81) |
Mean height (SD), cm | 1.56 (0.05) | 1.55 (0.05) |
Mean weight (SD), kg | 52.19 (4.41) | 52.84 (3.92) |
Mean BMI (SD), kg/m2 | 21.56 (1.51) | 21.96 (1.46) |
Mean years since menopause (SD), y | 14.91 (2.41) | 14.81 (2.47) |
Fallers (%), n | 2 (3%) | 3 (4%) |
Disease conditions | ||
Mean 25-OH-vitamin D (SD), ng/mL | 17.84 (4.19) | 17.87 (4.63) |
Mean femoral neck BMD (SD), g/cm2 | 0.663 (0.029) | 0.671 (0.018) |
Median T-score of femoral neck (IQR) | −2.20 (0.20) | −2.20 (0.20) |
Mean lean mass of left leg (SD), kg | 5.47 (0.55) | 5.50 (0.44) |
Mean TUG test (SD), s | 7.60 (0.48) | 7.66 (0.48) |
Mean deoxypyridinoline (SD), nmol/mmol | 7.61 (1.21) | 7.68 (1.12) |
Mean osteocalcin (SD), μg/L | 11.89 (2.33) | 11.68 (2.16) |
Mean estradiol (SD), pmol/L | 36.36 (5.14) | 35.09 (4.58) |
Mean endometrial thickness (SD), mm | 1.87 (0.31) | 1.79 (0.28) |
